Icosavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020
Market Capitalization	767	317	893	-
Market Cap Growth	-	-64.53%	-	-
Enterprise Value	546	106	613	-11
PE Ratio	-4.01	-3.45	-13.34	-
PS Ratio	-	544.35	114.49	-
PB Ratio	3.30	1.45	3.21	-
P/FCF Ratio	-5.26	-4.35	-22.59	-
P/OCF Ratio	-5.63	-5.14	-23.18	-
EV/Sales Ratio	-	182.54	78.51	-6.53
EV/EBITDA Ratio	-1.75	-1.14	-9.18	0.57
EV/EBIT Ratio	-1.70	-1.12	-9.17	0.57
EV/FCF Ratio	-2.26	-1.46	-15.49	0.74
Debt / Equity Ratio	0.03	0.04	-	-0.19
Debt / EBITDA Ratio	-0.08	-0.09	-	-0.27
Debt / FCF Ratio	-0.11	-0.12	-	-0.35
Quick Ratio	17.59	15.91	30.39	2.66
Current Ratio	18.06	16.24	31.02	2.77
Asset Turnover	0	0.00	0.04	0.08
Interest Coverage	-	-	-442.52	-55.96
Return on Equity (ROE)	-43.10%	-38.80%	-53.70%	107.90%
Return on Assets (ROA)	-39.50%	-36.00%	-32.20%	-95.60%
Return on Capital (ROIC)	-44.04%	-41.88%	-23.67%	86.00%
Earnings Yield	-12.61%	-28.96%	-7.50%	-
FCF Yield	-9.61%	-22.98%	-4.43%	-
Buyback Yield / Dilution	-25.87%	-121.11%	-700.18%	65.98%
Total Shareholder Return	-25.87%	-121.11%	-700.18%	65.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).